Undergoing a bone marrow transplant during adolescence, but not in adulthood, may lower the risk of stroke with SCD, a mouse ...
Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their ...
The U.S. Centers for Disease Control and Prevention reports that 1 out of every 365 Black people has sickle cell disease and the sickle cell trait affects 10% of Black people, compared to .3% of white ...
Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but ...
News-Medical.Net on MSN3d
Pioneering the world’s first CRISPR medicine for sickle cell diseaseWhen Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...
Medical Xpress on MSN8d
Novel bone marrow transplant can cure sickle cell diseaseA bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...
The following is a summary of “Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations ...
NEW HAVEN, Conn. (WTNH) — News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing. According to the Pew Research Center, overall, 18% ...
The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according ...
The National Academies of Sciences, Engineering, and Medicine Committee on Sickle Cell Disease in Social Security Disability Evaluations is inviting people with sickle cell disease (SCD) and ...
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to treat sickle cell disease (SCD). The trial aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback